{"id":"https://openalex.org/W2141784450","doi":"https://doi.org/10.1177/0269881113478475","title":"Systematic review of atomoxetine data in childhood and adolescent attention-deficit hyperactivity disorder 2009\u20132011: Focus on clinical efficacy and safety","display_name":"Systematic review of atomoxetine data in childhood and adolescent attention-deficit hyperactivity disorder 2009\u20132011: Focus on clinical efficacy and safety","alternate_titles":[],"publication_year":2013,"publication_date":"2013-02-25","ids":{"openalex":"https://openalex.org/W2141784450","doi":"https://doi.org/10.1177/0269881113478475","mag":"2141784450","pmid":"https://pubmed.ncbi.nlm.nih.gov/23438503"},"language":"en","primary_location":{"id":"doi:10.1177/0269881113478475","doi":"https://doi.org/10.1177/0269881113478475","is_oa":true,"landing_page_url":"https://doi.org/10.1177/0269881113478475","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2141784450"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1177/0269881113478475","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074167012","display_name":"Chris Bushe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095227","display_name":"Eli Lilly (United Kingdom)","ror":"https://ror.org/00psab413","country_code":"GB","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210095227"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Chris J Bushe","raw_affiliation_strings":["Eli Lilly and Company Ltd, Basingstoke, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company Ltd, Basingstoke, UK","institution_ids":["https://openalex.org/I4210095227"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065491639","display_name":"Nicola C. Savill","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095227","display_name":"Eli Lilly (United Kingdom)","ror":"https://ror.org/00psab413","country_code":"GB","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210095227"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nicola C Savill","raw_affiliation_strings":["Eli Lilly and Company Ltd, Basingstoke, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company Ltd, Basingstoke, UK","institution_ids":["https://openalex.org/I4210095227"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210095227"],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":{"value":4400,"currency":"USD","value_usd":4400},"fwci":1.4536,"has_fulltext":false,"cited_by_count":83,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.81979522,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"28","issue":"3","first_page":"204","last_page":"211"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10826","display_name":"Behavioral and Psychological Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3204","display_name":"Developmental and Educational Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atomoxetine","display_name":"atomoxetine","score":1.0},{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.9800000190734863},{"id":"https://openalex.org/keywords/childhood-adhd","display_name":"childhood ADHD","score":0.8569999933242798},{"id":"https://openalex.org/keywords/adolescent-adhd","display_name":"adolescent ADHD","score":0.9710000157356262},{"id":"https://openalex.org/keywords/onset-of-action","display_name":"onset of action","score":0.8109999895095825},{"id":"https://openalex.org/keywords/treatment-response-time","display_name":"treatment response time","score":0.7170000076293945},{"id":"https://openalex.org/keywords/methylphenidate","display_name":"methylphenidate","score":0.8460000157356262},{"id":"https://openalex.org/keywords/stimulant-medication","display_name":"stimulant medication","score":0.7889999747276306},{"id":"https://openalex.org/keywords/comparative-efficacy","display_name":"drug efficacy comparison","score":0.8610000014305115},{"id":"https://openalex.org/keywords/adverse-cardiovascular-events","display_name":"cardiovascular adverse events","score":0.7179999947547913},{"id":"https://openalex.org/keywords/suicide-risk","display_name":"suicide risk","score":0.8700000047683716},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.8080000281333923}],"concepts":[{"id":"https://openalex.org/C2778781522","wikidata":"https://www.wikidata.org/wiki/Q417240","display_name":"Atomoxetine","level":4,"score":0.9970349669456482},{"id":"https://openalex.org/C2777112843","wikidata":"https://www.wikidata.org/wiki/Q422112","display_name":"Methylphenidate","level":3,"score":0.7945464849472046},{"id":"https://openalex.org/C2909253567","wikidata":"https://www.wikidata.org/wiki/Q417240","display_name":"Atomoxetine hydrochloride","level":5,"score":0.7514057755470276},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5917736887931824},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5671492218971252},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.5243839621543884},{"id":"https://openalex.org/C2780557958","wikidata":"https://www.wikidata.org/wiki/Q211036","display_name":"Stimulant","level":2,"score":0.5012686252593994},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.42474961280822754},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3818705976009369},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.3322945237159729},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15573865175247192}],"mesh":[{"descriptor_ui":"D000069445","descriptor_name":"Atomoxetine Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008774","descriptor_name":"Methylphenidate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008774","descriptor_name":"Methylphenidate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011437","descriptor_name":"Propylamines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011437","descriptor_name":"Propylamines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018759","descriptor_name":"Adrenergic Uptake Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018759","descriptor_name":"Adrenergic Uptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1177/0269881113478475","doi":"https://doi.org/10.1177/0269881113478475","is_oa":true,"landing_page_url":"https://doi.org/10.1177/0269881113478475","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:23438503","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23438503","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of psychopharmacology (Oxford, England)","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1177/0269881113478475","doi":"https://doi.org/10.1177/0269881113478475","is_oa":true,"landing_page_url":"https://doi.org/10.1177/0269881113478475","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W1585901246","https://openalex.org/W1929084760","https://openalex.org/W1968567868","https://openalex.org/W1968639372","https://openalex.org/W1973632776","https://openalex.org/W1977761077","https://openalex.org/W1983863696","https://openalex.org/W1999774312","https://openalex.org/W2000125024","https://openalex.org/W2001006163","https://openalex.org/W2005898434","https://openalex.org/W2007567296","https://openalex.org/W2010675100","https://openalex.org/W2021696244","https://openalex.org/W2021898155","https://openalex.org/W2026268014","https://openalex.org/W2027058607","https://openalex.org/W2027451644","https://openalex.org/W2030029895","https://openalex.org/W2030490333","https://openalex.org/W2033214187","https://openalex.org/W2037430255","https://openalex.org/W2038569697","https://openalex.org/W2048092855","https://openalex.org/W2048386311","https://openalex.org/W2051954276","https://openalex.org/W2066273571","https://openalex.org/W2066896676","https://openalex.org/W2068014350","https://openalex.org/W2070081097","https://openalex.org/W2073229941","https://openalex.org/W2085230538","https://openalex.org/W2101805186","https://openalex.org/W2106133175","https://openalex.org/W2111812421","https://openalex.org/W2115766169","https://openalex.org/W2130386846","https://openalex.org/W2131972799","https://openalex.org/W2139510560","https://openalex.org/W2141637897","https://openalex.org/W2145525277","https://openalex.org/W2157382328","https://openalex.org/W2166617025","https://openalex.org/W2166748612","https://openalex.org/W2171074660","https://openalex.org/W2171785923","https://openalex.org/W4317648914"],"related_works":["https://openalex.org/W4211260601","https://openalex.org/W1983863696","https://openalex.org/W2133981367","https://openalex.org/W2212816893","https://openalex.org/W2442092354","https://openalex.org/W1996091936","https://openalex.org/W1914913155","https://openalex.org/W1504828730","https://openalex.org/W4411191289","https://openalex.org/W2367476440"],"abstract_inverted_index":{"BACKGROUND:":[0],"Clinicians":[1],"obtain":[2],"critical":[3,52],"prescribing":[4],"knowledge":[5],"from":[6,70,91],"clinical":[7,20,33,95,100,152],"papers":[8],"and":[9,45,59,102,105,108,183],"review":[10,18,66,109],"articles.":[11],"This":[12,97],"is":[13],"the":[14,83,171,174,205],"first":[15],"published":[16],"systematic":[17,65],"of":[19,41,43,54,67,116,147,173,207],"atomoxetine":[21,34,58,68,155,200],"data":[22,35,49,69,104,175],"covering":[23],"2009-2011.":[24],"OBJECTIVE:":[25],"We":[26],"aim":[27],"to":[28,39,137,160,188,199],"update":[29],"clinicians":[30],"on":[31],"current":[32],"with":[36],"specific":[37],"reference":[38],"time":[40,198],"onset":[42,115],"efficacy":[44,56,101,159,210],"maximal":[46],"efficacy.":[47],"These":[48],"may":[50,156],"allow":[51],"analysis":[53],"comparative":[55,209],"between":[57],"stimulant":[60],"medications.":[61],"METHODS:":[62],"A":[63],"formal":[64],"January":[71],"2009-June":[72],"2011":[73],"was":[74,80],"conducted.":[75],"The":[76,86],"search":[77,87],"term":[78],"used":[79],"\"atomoxetine\"":[81],"in":[82,125,164,168,191,204],"English":[84],"language.":[85],"yielded":[88],"747":[89],"citations":[90],"which":[92],"106":[93],"are":[94],"data.":[96],"paper":[98],"includes":[99],"safety":[103],"excludes":[106],"quality-of-life":[107],"papers.":[110],"RESULTS:":[111],"Atomoxetine":[112],"has":[113],"an":[114],"action":[117],"within":[118,122],"4":[119],"weeks":[120,133],"(possibly":[121],"1":[123],"week":[124],"subsequent":[126],"responders)":[127],"but":[128],"requires":[129],"at":[130],"least":[131],"12":[132],"for":[134],"full":[135],"response":[136,197],"be":[138,202],"demonstrated.":[139],"Treatment-na\u00efve":[140],"cohorts":[141],"(6-12":[142],"weeks)":[143],"report":[144],"effect":[145],"sizes":[146],"0.6-1.3.":[148],"Using":[149],"minimum":[150],"6-week":[151],"trial":[153],"criteria,":[154],"demonstrate":[157],"similar":[158,187],"methylphenidate":[161],"comparing":[162],"reduction":[163],"core":[165],"ADHD":[166],"symptoms":[167],"meta-analysis,":[169],"although":[170],"diversity":[172],"makes":[176],"interpretation":[177],"complex.":[178],"From":[179],"epidemiological":[180],"databases,":[181],"cardiovascular":[182],"suicide-related":[184],"events":[185],"were":[186],"those":[189],"seen":[190],"patients":[192],"taking":[193],"methylphenidate.":[194],"CONCLUSIONS:":[195],"Incremental":[196],"should":[201],"considered":[203],"design":[206],"future":[208],"trials.":[211]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2141784450","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":17},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
